Diabenol Review Article |
|
 |
|
 Diabenole (glibenclamide), also known as Glyburide (USAN) or Glucobene, is an anti-diabetic drug in a class of medications known as sulfonylureas. It is sold in doses of 1.25 mg, 1.75 mg, 2.5 mg, 3.5 mg and 5 mg, under the trade names Diabeta, Glynase and Micronase in the USA and Daonil, Semi-Daonil and Euglucon in the UK, Diabenol and Glucobene in other countries. It is also sold in combination with metformin under the trade name Glucovance.
Diabenole (generic name: glibenclamide, which is otherwise known as Glucobene and Glyburide) is a drug mainly used for the treatment of Type 2 Diabetes Mellitus, a disease condition wherein insulin is not used by the body normally and thus cannot be in charge of the amount of sugar present in the bloodstream, especially for individuals whose diabetes cannot be managed only through their diet. Glibenclamide belongs to a drug classification termed Sulfonylureas. By causing the pancreas to release insulin and helping the body use the released insulin effectively, this drug is able to decrease blood sugar. However, it is necessary for the pancreas to produce insulin first before this medication can function. Thus, it is not used for the treatment of Type 1 diabetes wherein the pancreas cannot produce insulin. Continue reading...
| Dosage |
Packing |
Price |
Add to basket |
| 1.75 mg |
120 tab |
USD 14.00 |
 |
| 3.5 mg |
30 tab ($0.23 per tab) |
USD 7.00 |
|
| 3.5 mg |
120 tab ($0.14 per tab) |
USD 17.00 |
|
|
|
Antidiabetic agents
 Diabenol Review Article
Buy here
|
|
My Basket
